Eli Lilly Raises Revenue Outlook as Weight-Loss Shots Offset Foundayo Sales Miss
Eli Lilly raised its revenue outlook, with weight-loss shot sales offsetting a Foundayo sales miss; its shares jumped.
Story updates
02:12:29 PM UTC
SquawkNews
UPDATE 3-更新 1-イーライ・リリー、減量薬で通期見通し上方修正、株価急騰 減量薬「ムンジャロ」と「ゼップバウンド」が第3四半期の業績予想を上回る要因に リリー社によると、５０万人以上の患者が